To identify MDM2–MDMX chromatin-associated protein signatures that drive breast cancer, we conducted a SILAC phospho-proteome screen in MDM2-proficient and deficient T47D breast cancer cells (mtp53 L194F). This evidence concerns the gene MDM2 and breast carcinoma.